Una píldora anticonceptiva masculina no hormonal nueva es altamente efectiva en los ratones y podrían comenzar las pruebas en humanos en el 2022, según los investigadores.
Related Posts
Type 1 Diabetes and Use of ‘Off-Label’ Drugs: Benefits, but Concerns, Too
MONDAY, Feb. 20, 2023 (HealthDay News) -- While people with type 1 diabetes can...
American Society of Hematology, Dec. 10 to 13
The annual meeting of the American Society of Hematology was held from Dec. 10...
San Antonio Breast Cancer Symposium, Dec. 6-10
The annual San Antonio Breast Cancer Symposium was held from Dec. 6 to 10 in...
Monoclonal Antibodies No Better Than Placebo for Early Parkinson Disease
THURSDAY, Aug. 4, 2022 (HealthDay News) -- The monoclonal antibodies...